TSE:141A stock news
This page provides real-time market news, earnings updates, and company announcements related to TRIAL Holdings.Inc. (TSE:141A).
All content is aggregated from trusted financial media and market data sources to help investors stay informed about key market movements and corporate developments.
Last updated as of 2026-03-17 11:08 JST
Structure Therapeutics' Oral Obesity Play Hinges on Upcoming FDA Meeting and Binary Phase 3 Path
101 finance2026-03-16 13:57:55
Beyond the Technology Sector: Discover How Biotech ETFs Are Leveraging the AI Boom
101 finance2026-03-16 14:48:51
CytomX Therapeutics' Pivotal Trial Endpoints and Diarrhea Prophylaxis Plans Don’t Match
101 finance2026-03-16 14:42:35
Phio Pharmaceuticals Announces "A Groundbreaking Approach to Treating Skin Cancer" in a Fireside Chat with Force Family Office
Finviz2026-03-16 15:33:49
Phio Pharmaceuticals Announces "A Groundbreaking Approach to Treating Skin Cancer" in a Fireside Chat with Force Family Office
Finviz2026-03-16 15:33:49
JNJ's Treatment for Bladder Cancer Achieves Primary Objective in Initial Phase Trial
101 finance2026-03-16 18:13:03
GSK's RSV Vaccine Arexvy Receives FDA Approval for At-Risk Younger Adult Population
101 finance2026-03-16 18:27:48
IBRX Shares Surge Following Advances in NK Cell Therapy Manufacturing
101 finance2026-03-16 18:39:39
Live Nation Court Case Exposes Concealed Monopoly Pressure—Why the Agreement Might Not Secure Its Hold on Ticket Sales
101 finance2026-03-16 18:48:59
Kyntra Bio Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
Finviz2026-03-16 20:09:45
Rhythm Pharmaceuticals Announces Topline Results from Phase 3 EMANATE Trial
Finviz2026-03-16 20:09:43
Cue Biopharma Reports Fourth Quarter and Full Year 2025 Financial Results and Business Highlights
Finviz2026-03-16 20:09:45
Key Information on This Obesity Drug Maker That Recently Secured a Fresh $7 Million Funding
101 finance2026-03-16 20:27:48
Getty Images (GETY) Fourth Quarter 2025 Earnings Call Transcript
101 finance2026-03-16 21:57:55
Samsara wins $30M in dispute over Motive’s advertising statements; Motive prevails in patent lawsuit
101 finance2026-03-16 22:03:10
Kyntra Bio (KYNB) Fourth Quarter 2025 Earnings Conference Call Transcript
101 finance2026-03-16 22:15:47
A Review of Q4 Earnings for Drug Development Inputs & Services Stocks: How Did Repligen (NASDAQ:RGEN) Compare to Its Peers?
101 finance2026-03-16 22:54:09
Stock Market Update for March 16: CytomX Therapeutics Jumps Following Encouraging Phase 1 Results in Colorectal Cancer
101 finance2026-03-16 23:03:38
Amgen Shares See Modest 0.01% Gain Amid 39.59% Surge in Trading Volume Ranking 130th in $0.77B Activity as Strong Earnings Drive Investor Interest
101 finance2026-03-16 23:06:41
Pfizer edges up by 0.11%, placing 133rd in trading activity, as regulatory successes contrast with ongoing revenue challenges
101 finance2026-03-16 23:09:48
This fund acquired $28 million worth of a struggling immunotherapy stock last quarter. What important information should long-term investors consider?
101 finance2026-03-17 00:09:42
Moderna shares rise by 1.43% after surpassing earnings expectations, yet trading activity remains sluggish, placing it at position 320.
101 finance2026-03-17 00:18:43
Penumbra's Slight 0.01% Increase Conceals 113% Jump in Trading Volume, Places 469th in Market Turnover
101 finance2026-03-17 01:06:42
Penumbra's Modest 0.01% Gain Masks 113% Volume Surge, Ranks 469th in Market Activity
101 finance2026-03-17 01:06:42
Phio Pharmaceuticals Announces "A Groundbreaking Approach to Treating Skin Cancer" in a Fireside Chat with Force Family Office
Finviz2026-03-16 15:33:49
JNJ's Treatment for Bladder Cancer Achieves Primary Objective in Initial Phase Trial
101 finance2026-03-16 18:13:03
GSK's RSV Vaccine Arexvy Receives FDA Approval for At-Risk Younger Adult Population
101 finance2026-03-16 18:27:48
IBRX Shares Surge Following Advances in NK Cell Therapy Manufacturing
101 finance2026-03-16 18:39:39
Live Nation Court Case Exposes Concealed Monopoly Pressure—Why the Agreement Might Not Secure Its Hold on Ticket Sales
101 finance2026-03-16 18:48:59
Kyntra Bio Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
Finviz2026-03-16 20:09:45
Rhythm Pharmaceuticals Announces Topline Results from Phase 3 EMANATE Trial
Finviz2026-03-16 20:09:43
Cue Biopharma Reports Fourth Quarter and Full Year 2025 Financial Results and Business Highlights
Finviz2026-03-16 20:09:45
Key Information on This Obesity Drug Maker That Recently Secured a Fresh $7 Million Funding
101 finance2026-03-16 20:27:48
Getty Images (GETY) Fourth Quarter 2025 Earnings Call Transcript
101 finance2026-03-16 21:57:55
Samsara wins $30M in dispute over Motive’s advertising statements; Motive prevails in patent lawsuit
101 finance2026-03-16 22:03:10
Kyntra Bio (KYNB) Fourth Quarter 2025 Earnings Conference Call Transcript
101 finance2026-03-16 22:15:47
A Review of Q4 Earnings for Drug Development Inputs & Services Stocks: How Did Repligen (NASDAQ:RGEN) Compare to Its Peers?
101 finance2026-03-16 22:54:09
Stock Market Update for March 16: CytomX Therapeutics Jumps Following Encouraging Phase 1 Results in Colorectal Cancer
101 finance2026-03-16 23:03:38
Amgen Shares See Modest 0.01% Gain Amid 39.59% Surge in Trading Volume Ranking 130th in $0.77B Activity as Strong Earnings Drive Investor Interest
101 finance2026-03-16 23:06:41
Pfizer edges up by 0.11%, placing 133rd in trading activity, as regulatory successes contrast with ongoing revenue challenges
101 finance2026-03-16 23:09:48
This fund acquired $28 million worth of a struggling immunotherapy stock last quarter. What important information should long-term investors consider?
101 finance2026-03-17 00:09:42
Moderna shares rise by 1.43% after surpassing earnings expectations, yet trading activity remains sluggish, placing it at position 320.
101 finance2026-03-17 00:18:43
Penumbra's Slight 0.01% Increase Conceals 113% Jump in Trading Volume, Places 469th in Market Turnover
101 finance2026-03-17 01:06:42
Penumbra's Modest 0.01% Gain Masks 113% Volume Surge, Ranks 469th in Market Activity
101 finance2026-03-17 01:06:42
TSE:141A stock price change
On the last trading day, TSE:141A stock closed at 4070.00 JPY, with a price change of 1.24% for the day.
Trade stock perpsTSE:141A stock detailsAbout Bitget
The world's first Universal Exchange (UEX), enabling users to trade not only cryptocurrencies, but also stocks, ETFs, forex, gold, and real-world assets (RWA).
Learn more